Literature DB >> 34349347

Blocking circ_0014130 suppressed drug resistance and malignant behaviors of docetaxel resistance-acquired NSCLC cells via regulating miR-545-3p-YAP1 axis.

Dongjie Du1, Xiaoci Cao1, Xinbo Duan1, Xianbo Zhang1.   

Abstract

Recent evidences have claimed that circular RNAs are deregulated in docetaxel (DTX) resistance in malignant tumors, including non-small-cell lung cancer (NSCLC). Hsa_circ_0014130 (circ_0014130) is a new biomarker in NSCLC. However, its role in DTX-resistant NSCLC remained to be annotated. In this study, real-time PCR was used to measure expression of circ_0014130, and circ_0014130 was upregulated in NSCLC tumors and DTX-resistant NSCLC cells (NCI-H1299/DTX and A549/DTX). MTT assay analyzed the half inhibitory concentration (IC50) of DTX, and it was lowered by circ_0014130 interference in DTX-resistant NSCLC cells. Moreover, colony formation assay, flow cytometry, transwell assays, and xenograft tumor model revealed that silencing circ_0014130 facilitated apoptosis rate of DTX-resistant NSCLC cells, suppressed the colony formation, migration and invasion, and retarded xenograft tumor growth in nude mice. Dual-luciferase reporter assay and RNA immunoprecipitation confirmed that circ_0014130 was one competing endogenous RNA (ceRNA) for miRNA (miR)-545-3p, and circ_0014130 modulated expression of yes-associated protein 1 (YAP1), a target gene for miR-545-3p. YAP1 upregulation and miR-545-3p downregulation were allied with circ_0014130 upregulation in NSCLC tumors and DTX-resistant NSCLC cells. Functionally, downregulating miR-545-3p could abate the effects of circ_0014130 knockdown in DTX-resistant NSCLC cells in vitro, whereas its overexpression exerted similar effects of circ_0014130 knockdown. Either, restoring YAP1 partially reversed miR-545-3p effects in DTX-resistant NSCLC cells. Collectively, there might be a novel circ_0014130-miR-545-3p-YAP1 ceRNA pathway in regulation of chemoresistance and malignant behaviors of DTX-resistant NSCLC cells, suggesting a potential therapeutic approach for DTX resistance.
© The Author(s), under exclusive licence to Springer Nature B.V. 2021.

Entities:  

Keywords:  DTX resistance; NSCLC; YAP1; circ_0014130; miR-545-3p

Year:  2021        PMID: 34349347      PMCID: PMC8319228          DOI: 10.1007/s10616-021-00478-z

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.040


  40 in total

1.  MicroRNA‑506‑3p reverses gefitinib resistance in non‑small cell lung cancer by targeting Yes‑associated protein 1.

Authors:  Junfei Zhu; Lianqin Tao; Litong Jin
Journal:  Mol Med Rep       Date:  2018-11-29       Impact factor: 2.952

2.  Ultrastructure, morphology and crystal growth of biogenic and synthetic apatites.

Authors:  B R Heywood; N H Sparks; R P Shellis; S Weiner; S Mann
Journal:  Connect Tissue Res       Date:  1990       Impact factor: 3.417

Review 3.  Hippo vs. Crab: tissue-specific functions of the mammalian Hippo pathway.

Authors:  Miki Nishio; Tomohiko Maehama; Hiroki Goto; Keisuke Nakatani; Wakako Kato; Hirofumi Omori; Yosuke Miyachi; Hideru Togashi; Yohei Shimono; Akira Suzuki
Journal:  Genes Cells       Date:  2017-01       Impact factor: 1.891

4.  Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance.

Authors:  Jeong Eun Lee; Hee Sun Park; Dahye Lee; Geon Yoo; Tackhoon Kim; Haeyon Jeon; Min-Kyung Yeo; Choong-Sik Lee; Jae Young Moon; Sung Soo Jung; Ju Ock Kim; Sun Young Kim; Dong Il Park; Yeon Hee Park; Jae Cheol Lee; In-Jae Oh; Dae Sik Lim; Chaeuk Chung
Journal:  Biochem Biophys Res Commun       Date:  2016-04-20       Impact factor: 3.575

Review 5.  Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.

Authors:  Chunyan Li; Lin Zhang; Guangping Meng; Qi Wang; Xuejiao Lv; Jie Zhang; Junyao Li
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-19       Impact factor: 4.553

6.  circPIP5K1A serves as a competitive endogenous RNA contributing to ovarian cancer progression via regulation of miR-661/IGFBP5 signaling.

Authors:  Yi Sun; Xue Li; Aozheng Chen; Weihui Shi; Lei Wang; Ruhai Yi; Jin Qiu
Journal:  J Cell Biochem       Date:  2019-08-26       Impact factor: 4.429

7.  Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.

Authors:  Zhiyuan Shen; Le Zhou; Chao Zhang; Jun Xu
Journal:  Cancer Lett       Date:  2019-10-05       Impact factor: 8.679

8.  Clinical characteristics of 274 non-small cell lung cancer patients in China.

Authors:  Yan Chen; Sheng Han; Min-Juan Zheng; Yan Xue; Wen-Chao Liu
Journal:  Onkologie       Date:  2013-04-02

Review 9.  Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review.

Authors:  Pramod Kumar; Kaisar Raza; Lokesh Kaushik; Ruchi Malik; Shweta Arora; Om Prakash Katare
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

10.  Hsa_circ_0003998 Promotes Chemoresistance via Modulation of miR-326 in Lung Adenocarcinoma Cells.

Authors:  Wanjun Yu; Weidong Peng; Hanyun Sha; Jipeng Li
Journal:  Oncol Res       Date:  2019-02-14       Impact factor: 5.574

View more
  4 in total

1.  Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.

Authors:  Liang Chen; Yarong Song; Teng Hou; Xuexiang Li; Lulin Cheng; Yunxue Li; Yifei Xing
Journal:  J Exp Clin Cancer Res       Date:  2022-06-03

Review 2.  Advances in the Study of CircRNAs in Tumor Drug Resistance.

Authors:  Song Wang; Long Qian; Tingting Cao; Li Xu; Yan Jin; Hao Hu; Qingsheng Fu; Qian Li; Ye Wang; Jiawei Wang; Yabin Xia; Xiaoxu Huang
Journal:  Front Oncol       Date:  2022-05-09       Impact factor: 5.738

Review 3.  The Role of Circular RNAs in the Drug Resistance of Cancers.

Authors:  Xin-Yuan Liu; Qi Zhang; Jing Guo; Peng Zhang; Hua Liu; Zi-Bin Tian; Cui-Ping Zhang; Xiao-Yu Li
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

4.  Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR-6751-3p to regulate the expression of ZNF300.

Authors:  Lingyan Ding; Lizhi Li; Zhaohui Tang
Journal:  Thorac Cancer       Date:  2022-02-15       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.